Non-adherence to the therapy in Crohn's disease patients: Prevalence and risk factors;Não-adesão ao tratamento em pacientes com doença de Crohn: Prevalência e fatores de risco

Arquivos de Gastroenterologia

Volumn 46, Issue 3, 2009, Pages 183-189

  Cornélio, Rita De Cássia Azevedo Couto ^a   Pinto, André Luis Tavares ^a   Pace, Fábio Heleno De Lima ^a   Moraes, Jussara Paixão ^a   Chebli, Júlio Maria Fonseca ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

Author keywords

Crohn disease; Drug administration schedule; Treatment refusal

Indexed keywords

AZATHIOPRINE; PREDNISONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CROHN DISEASE; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREVALENCE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK FACTOR; TREATMENT REFUSAL;

ADULT; AGED; CROHN DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; YOUNG ADULT;

EID: 70449643534     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032009000300008     Document Type: Article

References (38)

1. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571
2. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohns disease activity index. National Cooperative Crohns Disease Study. Gastroenterology. 1976;70:439-444
3. Botega NJ, Bio MR, Zomignani A, Garcia Jr C, Pereira WAB. Transtornos do humor em enfermaria de clínica médica e validação de escala de medida (HAD) de ansiedade e depressão. Rev Saúde Publica. 1995;29:355-363
4. Case Management Society of America. Guidelines from the Case Management Society of America for improving patient adherence to medication therapies. CMGA-1, 2004.
5. D'Inca R, Bertomoro P, Mazzocco K, Vettorato MG, Rumiati R, Sturniolo GC. Risk factors for non-adherence to medication in inflammatory bowel disease. Aliment Pharmacol Ther. 2008;27:166-172 (Pubitemid 350256604)
6. Delgado AB, Lima ML. Contributo para a validação concorrente de uma medida de adesão aos tratamentos. Psicol Saúde Doenças. 2001;2:81-100.
7. Dewulf NL, Monteiro RA, Passos ADC, Troncon LE. Adesão ao tratamento medicamentoso em pacientes com doenças gastrointestinais crônicas acompanhados no ambulatório de um hospital universitário. Rev Bras Cienc Farm. 2006;42:575-584
8. Dewulf NL, Monteiro RA, Passos ADC, Vieira EM, Troncon LE. Adesão ao tratamento medicamentoso de pacientes com doenças inflamatórias intestinais acompanhados no ambulatório de um hospital universitário. Arq Gastroenterol. 2007;44:289-296
9. Ediger JP, Walker JR, Graff L, Lix L, Clara I, Rawsthorne P, Rogala L, Miller N, McPhail C, Deering K, Bernstein CN. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol. 2007;102:1417-1426 (Pubitemid 46976288)
10. Fellows IW, Freeman JG, Holmes GK. Crohn's disease in the city of Derby, 1951-1985. Gut. 1990;31:1262-1265
11. Gaburri PD, Chebli JM, Castro LE, Ferreira JO, Lopes MH, Ribeiro AM, Alves RA, Froese EC, Oliveira KS, Gaburri AK, Gaburri D, Meirellers GS, Souza AF. Epidemiologia, aspectos clínicos e evolutivos da doença de Crohn: um estudo de 60 casos. Arq Gastroenterol. 1998;35:240-246 (Pubitemid 29159489)
12. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna, 1998. Inflamm Bowel Dis. 2000;6:8-15.
13. Gorenstein C, Andrade L. Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety inventory in Brazilian subjects. Braz J Med Biol Res. 1996;29:453-457 (Pubitemid 126501480)
14. Haynes B, Taylor BW, Sackett DL. Compliance in healthcare. Baltimore, Maryland: Univertsity Press; 1981.
15. Ickovics RJ, Meisler WA. Adherence in AIDS clinical trials: a framework for clinical research and care. J Clin Epidemiol. 1997;50:385-391 (Pubitemid 27223267)
16. Kane SV, Cohen RD, Aikens JE, Hanauer SB. Prevalence of nonadherence with maintenance mesalasine in quiescent ulcerative colitis. Am J Gastroenterol. 2001;96:2929-2933
17. Kane SV, Huo D, Aikens J, Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med. 2003;114:39-43. (Pubitemid 36126514)
18. Kane SV. Systematic review: adherence issues in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 2006;23:577-585
19. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2004;99:1371-1385 (Pubitemid 39062279)
20. Lashner BA. Clinical features, laboratory findings, and course of Crohn's disease. In: Kirsner JB, editor. Inflammatory bowel disease. Chicago: Saunders; 2000. p.305-314
21. Leite SN, Vasconcellos MPC. Adesão à terapêutica medicamentosa: elementos para a discussão de conceitos e pressupostos adotados na literatura. Ciênc Saúde Coletiva. 2003;8:775-782
22. Lennard-Jones E. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24:2-6.
23. López San Román A, Bermejo F, Carrera E, Pérez-Abad M, Boixeda D. Adherence to treatment in inflammatory bowel disease. Rev Esp Enferm Dig. 2005;97:249-257 (Pubitemid 40755660)
24. Mackner LM, Crandall WV. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:1006-1012 (Pubitemid 41580015)
25. Michaud PA, Suris JC, Viner R. The adolescent with a chronic condition. Part II: Healthcare provision. Arch Dis Child. 2004;89:943-949
26. Milstein-Moscati I, Persano S, Castro LLC. Aspectos metodológicos e comportamentais da adesão à terapêutica. In: Castro LLC, org. Fundamentos de farmacoepidemiologia. São Paulo: Agrupuram; 2000. p.171-179
27. Miszputen JS. Doenças inflamatórias intestinais - opções terapêuticas. J Bras Gastroenterol. 2007;7:5-60.
28. Morisky DE, Green W, Levine DM. Concurrent and predicitive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
29. Nigro G, Angelini G, Grosso SB, Caula G, Sategna-Guidette C. Psychatric predictors of non compliance in inflammatory bowel disease. J Clin Gastroenterol. 2001;32:61-68
30. Programa das Nações Unidas para o Desenvolvimento. [online]. 2008. Disponível em: http://www.pnud.org.br/raca/reportagens/index.php? id01=1608&lay=rac.
31. Rose JDR, Roberts GM, Williams G, Mayberry JF, Rhodes J. Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut. 1988;29:346-351 (Pubitemid 18082151)
32. Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, Wild GE, Cohen A, Dobkin PL. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003;98:1535-1544 (Pubitemid 36875345)
33. Shale MJ, Riley AS. Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2003;18:191-198 (Pubitemid 36951655)
34. Shanahan F. Crohn's disease. Lancet. 2002;359:62-69
35. Souza MH, Troncon LE, Rodrigues CM, Viana CF, Onofre PH, Monteiro RA, Passos AD, Martinelli AL, Meneghelli UG. Evolução da ocorrência (1980-1999) da doença de Crohn e da retocolite ulcerativa idiopática e análise das suas características clínicas em um hospital universitário do sudeste do Brasil. Arq Gastroenterol. 2002;39:98-105.
36. Vlasnik JJ, Aliotta SL, DeLor B. Evidence-based assessment and intervention strategies to increase adherence to prescribed medication plans. Case Manager. 2005;16:55-59 (Pubitemid 40488331)
37. Vlasnik JJ, Aliotta SL, DeLor B. Medication adherence: factors influencing complience with precribed medication plans. Case Manager. 2005;16:47-51. (Pubitemid 40488329)
38. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-370